UK small-cap RNS · 25 Sep 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
| Date | Company | Mcap | Who | Amount | % mcap | ||
|---|---|---|---|---|---|---|---|
| 25 Sep | Trufin TRU | £54m | James van den Bergh · Chief Executive Officer
|
Buy | £24k | 0.05% | |
| 25 Sep | B90 Holdings B90 | £19m | Andrew McIver · Non-Executive Chairman
|
Buy | £10k | 0.05% | |
| 25 Sep | AB Dynamics ABDP | £182m | Andrew Lewis · Interim Chief Financial Officer Sarah Matthews-DeMers · Chief Executive Officer
|
Buy | £10k | 0.01% | |
| 25 Sep | Georgia Capital CGEO | £1,243m | Maria Chatti-Gautier · PDMR - Non-Executive Director
|
Buy | – | – | |
| 25 Sep | Oxford Biomedica OXB | £622m | A director · Non-Executive Director
|
Buy | – | – | |
| 25 Sep | Hays HAS | £938m | Tom Way · CEO, UK&I, PDMR Mark Dearnley · CEO, PDMR
|
Sell | – | – |
Purchases and sales with the directors' own money, from the forms they file (MAR article 19); awards, vesting, option exercises, share plans and sales for tax are under All. Not investment advice.